World Cancer Institute

World Cancer Institute is a biotechnology company focused on the development of "DNA programmable pharmaceutics" for the treatment of various cancers. The company's lead platform, CancerVX (also known as OncoVacx), is an OncoEpigenetic DNA Immuno Therapy designed to address the root genetic causes of cancer by targeting DNA aberrations and gene expression. The therapy utilizes a trivalent approach that combines DNA demethylation, histone regulation, and neuro-immuno modulation to achieve disease modification. Clinical protocols have demonstrated effectiveness in treating advanced solid tumors, including inflammatory breast cancer, as well as hematological malignancies. By triangulating multiple epigenetic and immunological pathways, World Cancer Institute aims to provide a personalized and bioactive alternative to traditional chemotherapy.